InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: None

Friday, 07/29/2016 9:02:32 PM

Friday, July 29, 2016 9:02:32 PM

Post# of 463641
Any small cap or micro cap biotech company that has a lick of promise and intriguing compounds in clinical trials is going to attract the attention of AF, JF, and their hedge fund collaborators. They play the odds that most these drugs fail and simply work off that premise. They start with a narrative (the company is a scam and the drugs or worthless) before even investigating the company in depth. Whatever information they find that can be spun to fit their narrative they exploit. Never anything positive is written until writing is on the wall that it is a success. Then they make excuses or just refuse to comment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News